FIELD: medicine.
SUBSTANCE: proposed is a test system for diagnosing the pathogenic variant NC_000006.11:g. 16327867-16327953 in the ATXN1 gene associated with type 1 spinocerebellar ataxia. The test system includes a PCR mixture for the first amplification round and a PCR mixture for the second amplification round.
EFFECT: invention ensures the creation of a test system for diagnosing a pathogenic variant in the ATXN1 gene with a dual detection system, direct and indirect.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF LOUIS-BAR SYNDROME | 2021 |
|
RU2777081C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR ACHONDROPLASIA | 2022 |
|
RU2795796C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR BLEPHAROPHIMOSIS, PTOSIS AND EPICANTHUS REVERSAL SYNDROME TYPE 1,2 | 2022 |
|
RU2799538C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF BREAST AND OVARIAN CANCER | 2021 |
|
RU2777091C1 |
METHOD FOR PREIMPLANTATION GENETIC TESTING OF TYPE 1 HEREDITARY MULTIPLE OSTEOCHONDROMAS | 2022 |
|
RU2795824C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR FANCONI ANEMIA | 2022 |
|
RU2792147C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR ALPORT SYNDROME | 2022 |
|
RU2795481C1 |
PREIMPLANTATION METHOD OF MARTINE-BELL SYNDROME GENETIC TESTING | 2022 |
|
RU2796834C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF TYPE 1 FAMILIAL FOCAL EPILEPSY | 2021 |
|
RU2777084C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY | 2021 |
|
RU2772938C1 |
Authors
Dates
2022-03-30—Published
2021-03-29—Filed